Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky acquired 12,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were acquired at an average price of $20.00 per share, with a total value of $250,000.00. Following the completion of the purchase, the director owned 12,500 shares in the company, valued at approximately $250,000. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Alan Sebulsky also recently made the following trade(s):
- On Monday, June 15th, Alan Sebulsky acquired 9,065 shares of Parabilis Medicines stock. The shares were acquired at an average price of $26.49 per share, with a total value of $240,131.85.
- On Friday, June 12th, Alan Sebulsky acquired 8,435 shares of Parabilis Medicines stock. The shares were acquired at an average price of $27.67 per share, with a total value of $233,396.45.
Parabilis Medicines Stock Performance
Shares of NASDAQ PBLS opened at $26.03 on Thursday. Parabilis Medicines, Inc. has a 12 month low of $24.51 and a 12 month high of $34.47.
See Also
- Five stocks we like better than Parabilis Medicines
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
